NEW YORK (GenomeWeb) – Genome Compiler and De Novo DNA today announced a collaboration to create a comprehensive synthetic biology solution.
Under the agreement, Genome Compiler will incorporate De Novo DNA's RBS Calculator and RBS Library Calculator software design methods into its synthetic biology platform. De Novo DNA's methods make specific predictions to improve the performance of genetic systems.
"Incorporating De Novo DNA's RBS Calculator will enable our users to predict protein expression across a variety of industrial relevant hosts," Genome Compiler CEO Omri Drory said in a statement, adding the new solution will provide the industry a platform to serve all its synthetic biology needs.
Financial and other terms of the deal were not disclosed.
Genome Compiler is a synthetic biology software company based in Los Altos, Calif. De Novo DNA is a biophysics-based genetic software firm headquartered in State College, Pa.